IHT Wealth Management LLC Makes New Investment in Solventum Co. (NYSE:SOLV)

IHT Wealth Management LLC purchased a new position in Solventum Co. (NYSE:SOLV) during the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund purchased 3,873 shares of the company’s stock, valued at approximately $266,000.

Other institutional investors and hedge funds have also made changes to their positions in the company. Deseret Mutual Benefit Administrators acquired a new stake in shares of Solventum during the second quarter worth $25,000. Hollencrest Capital Management acquired a new stake in shares of Solventum during the second quarter worth $25,000. Richard W. Paul & Associates LLC acquired a new stake in shares of Solventum during the second quarter worth $26,000. Family Firm Inc. acquired a new stake in shares of Solventum during the second quarter worth $26,000. Finally, Copeland Capital Management LLC acquired a new stake in shares of Solventum during the third quarter worth $26,000.

Wall Street Analysts Forecast Growth

Several equities research analysts have recently commented on the stock. Mizuho assumed coverage on shares of Solventum in a research note on Wednesday, December 4th. They set a “neutral” rating and a $70.00 price objective for the company. Piper Sandler lifted their price objective on shares of Solventum from $71.00 to $75.00 and gave the stock a “neutral” rating in a research note on Friday, November 8th. Morgan Stanley boosted their target price on shares of Solventum from $60.00 to $73.00 and gave the company an “equal weight” rating in a research report on Monday, November 11th. The Goldman Sachs Group boosted their target price on shares of Solventum from $48.00 to $54.00 and gave the company a “sell” rating in a research report on Monday, August 12th. Finally, BTIG Research initiated coverage on shares of Solventum in a research report on Thursday, September 5th. They set a “neutral” rating for the company. One research analyst has rated the stock with a sell rating, nine have issued a hold rating and one has issued a buy rating to the company’s stock. According to data from MarketBeat, Solventum currently has a consensus rating of “Hold” and a consensus price target of $68.29.

Solventum Trading Up 1.0 %

Shares of Solventum stock opened at $70.64 on Tuesday. The firm has a 50-day simple moving average of $70.71 and a two-hundred day simple moving average of $62.96. Solventum Co. has a fifty-two week low of $47.16 and a fifty-two week high of $96.05. The company has a current ratio of 1.15, a quick ratio of 0.83 and a debt-to-equity ratio of 2.45.

Solventum Company Profile

Solventum Corporation, a healthcare company, engages in the developing, manufacturing, and commercializing a portfolio of solutions to address critical customer and patient needs. It operates through four segments: Medsurg, Dental Solutions, Health Information Systems, and Purification and Filtration.